Female Breast Cancer Clinical Trials

28 clinical trials for Female Breast Cancer across international registries, including 5 currently recruiting participants. Compare status, phase, eligibility criteria and locations.

• IIT2023-09-Chung-UpfrontTAD: Upfront TAD/SNB in Patients With Breast Cancer With Nodal Metastases — RECRUITING · PHASE2
• PROOFS-Registry - Premenopausal Women With Breast Cancer Optimally Treated With OFS — RECRUITING
• Culturally Adapting an Intervention to Increase Genetic Testing in African American Cancer Survivors — RECRUITING · NA
• A Study of a Comprehensive Prevention Program to Reduce Lymphedema After Axillary Lymph Node Dissection in People With Breast Cancer — RECRUITING · PHASE3
• Melatonin Supplementation and Exercise Program in Breast Cancer Women — RECRUITING · NA
• A Study of 1 8F-FDHT PET/MRIScans in Women With Breast Cancer — WITHDRAWN · PHASE1
• Exercise Program on Pain, Physical Function, and Quality of Life in Breast Cancer Survivors — ACTIVE_NOT_RECRUITING · NA
• PrefeRences And ChemoTherapy In Breast Cancer patiEnts — OTHER
• Pulsed Electromagnetic Fields for Analgesia Post Mastectomy — OTHER · NA
• Exercise, Gut Microbiome, and Breast Cancer: Increasing Reach to Underserved Populations — COMPLETED · NA
• Effect of TIVA Propofol vs Sevoflurane Anaesthetic on Serum Biomarkers and on PBMCs in Breast Cancer Surgery — WITHDRAWN · NA
• Efficacy of Neoadjuvant Endocrine Therapy Compared to Chemotherapy in Breast Cancer Patients — OTHER · PHASE1
• Ultra-hypofractionated Radiotherapy in Breast Cancer Patients — OTHER
• Acupuncture for Joint Symptoms in Patients With Breast Cancer — TERMINATED · NA
• This is a Multicenter, Randomized, Double-blind, Placebo-controlled Phase III Clinical Study Evaluating the Efficacy and Safety of FCN-437c Versus Placebo in Combination With Letrozole or Anastrozole ± Goserelin in Women With HR+ and HER2- Advanced Breast Cancer. — OTHER · PHASE3
• This is a Multicenter, Randomized, Double-blind, Placebo-controlled Phase III Clinical Study Evaluating the Efficacy and Safety of FCN-437c in Combination With Fluvestrant ± Goseraline Versus Placebo Combined With Fulvestrant ± Goserelin in Women With HR+ and HER2- Advanced Breast Cancer. — OTHER · PHASE3
• An Intervention for Female Breast CANcer: Acceptance and Commitment Therapy (I-CAN-ACT) for Depression and Physical Pain — OTHER · NA
• Place of Comprehensive Geriatric Assessment in Patients ≥ 75 Years Care, With Breast Cancer, After Screening With FOG (Oncology Geriatric Filter) — OTHER · NA
• Tomosymthesis for Breast Mass Lesion Characterization — OTHER
• Yoga on QOL Physiological Distress&Fatigue, on Patients Affected by Breast Cancer in Adjuvant Radiotherapy — OTHER · NA
• Estrogen for Triple Negative Breast Cancer — TERMINATED · PHASE2
• Dose Dense TC + Pegfilgrastim Support for Breast Cancer — COMPLETED · PHASE2
• Silent Breast Cancer A Study of the Disease Prevalence Held by Imaging Guided Biopsies in Autopsy Specimens — OTHER · NA
• Side Effect Prevention Training (SEPT) for Nocebo Effects in Breast Cancer Patients — OTHER · NA
• Expectations and Side Effects of Endocrine Therapy in Women With Breast Cancer — OTHER
• Female Sexual Dysfunction in Breast Cancer Patients — OTHER
• Adjuvant Endocrine Therapy for Estrogen Receptor-beta Positive Triple Negative Breast Cancer — OTHER · PHASE4
• Breast Cancer in Young Women: Is it Different? — SUSPENDED

Refine this search